JPY 972.0
(-0.92%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | 40.95 Million JPY | -93.92% |
2022 | 673.51 Million JPY | -38.64% |
2021 | 1.09 Billion JPY | 83.54% |
2020 | 598.04 Million JPY | -33.72% |
2019 | 902.32 Million JPY | 63.13% |
2018 | 553.12 Million JPY | -57.72% |
2017 | 1.3 Billion JPY | 17.46% |
2016 | 1.11 Billion JPY | 251.11% |
2015 | 317.18 Million JPY | -42.01% |
2014 | 546.93 Million JPY | 33.73% |
2013 | 408.98 Million JPY | 34.49% |
2012 | 304.1 Million JPY | 289.37% |
2011 | 78.1 Million JPY | -47.87% |
2010 | 149.81 Million JPY | -53.51% |
2009 | 322.21 Million JPY | 306.15% |
2008 | -156.29 Million JPY | 7.51% |
2007 | -168.98 Million JPY | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q1 | 175 Million JPY | 166.2% |
2023 Q4 | -264.34 Million JPY | -394.34% |
2023 Q1 | -4.35 Million JPY | 98.35% |
2023 Q2 | 149.7 Million JPY | 3537.52% |
2023 FY | 40.95 Million JPY | -93.92% |
2023 Q3 | 89.8 Million JPY | -40.01% |
2022 Q1 | 362.11 Million JPY | 48.58% |
2022 Q2 | 427.44 Million JPY | 18.04% |
2022 FY | 673.51 Million JPY | -38.64% |
2022 Q3 | 148.29 Million JPY | -65.31% |
2022 Q4 | -264.33 Million JPY | -278.25% |
2021 Q4 | 243.72 Million JPY | 40.97% |
2021 Q1 | 457.63 Million JPY | 99.16% |
2021 FY | 1.09 Billion JPY | 83.54% |
2021 Q2 | 223.42 Million JPY | -51.18% |
2021 Q3 | 172.88 Million JPY | -22.62% |
2020 Q4 | 229.78 Million JPY | -31.74% |
2020 FY | 598.04 Million JPY | -33.72% |
2020 Q3 | 336.62 Million JPY | 132.12% |
2020 Q2 | 145.02 Million JPY | 227.91% |
2020 Q1 | -113.38 Million JPY | -131.42% |
2019 Q4 | 360.91 Million JPY | 122.92% |
2019 Q1 | 243.55 Million JPY | 630.98% |
2019 Q2 | 135.95 Million JPY | -44.18% |
2019 Q3 | 161.9 Million JPY | 19.08% |
2019 FY | 902.32 Million JPY | 63.13% |
2018 Q2 | 150.66 Million JPY | -41.57% |
2018 Q3 | 111.28 Million JPY | -26.14% |
2018 Q4 | 33.31 Million JPY | -70.06% |
2018 FY | 553.12 Million JPY | -57.72% |
2018 Q1 | 257.85 Million JPY | -26.5% |
2017 Q1 | 292.56 Million JPY | -29.3% |
2017 Q3 | 296.16 Million JPY | -19.64% |
2017 Q2 | 368.54 Million JPY | 25.97% |
2017 FY | 1.3 Billion JPY | 17.46% |
2017 Q4 | 350.82 Million JPY | 18.46% |
2016 Q3 | 293.35 Million JPY | 212.54% |
2016 Q2 | 93.86 Million JPY | -69.98% |
2016 FY | 1.11 Billion JPY | 251.11% |
2016 Q4 | 413.82 Million JPY | 41.07% |
2016 Q1 | 312.61 Million JPY | 1227.49% |
2015 FY | 317.18 Million JPY | -42.01% |
2015 Q1 | 140.89 Million JPY | -24.66% |
2015 Q2 | 16.22 Million JPY | -88.48% |
2015 Q3 | 136.51 Million JPY | 741.45% |
2015 Q4 | 23.54 Million JPY | -82.75% |
2014 Q2 | 122.5 Million JPY | 436.89% |
2014 Q1 | 22.81 Million JPY | -75.3% |
2014 FY | 546.93 Million JPY | 33.73% |
2014 Q4 | 187.01 Million JPY | -12.85% |
2014 Q3 | 214.59 Million JPY | 75.18% |
2013 FY | 408.98 Million JPY | 34.49% |
2013 Q4 | 92.38 Million JPY | -36.44% |
2013 Q3 | 145.34 Million JPY | 134.29% |
2013 Q2 | 62.03 Million JPY | -43.21% |
2013 Q1 | 109.23 Million JPY | 0.51% |
2012 FY | 304.1 Million JPY | 289.37% |
2012 Q4 | 108.68 Million JPY | -24.62% |
2012 Q1 | 99.92 Million JPY | -32.27% |
2012 Q2 | -48.67 Million JPY | -148.71% |
2012 Q3 | 144.17 Million JPY | 396.22% |
2011 Q4 | 147.53 Million JPY | 307.29% |
2011 Q2 | -31.23 Million JPY | -194.72% |
2011 FY | 78.1 Million JPY | -47.87% |
2011 Q1 | 32.98 Million JPY | 1631.15% |
2011 Q3 | -71.17 Million JPY | -127.84% |
2010 Q4 | -2.15 Million JPY | -102.43% |
2010 Q2 | 10.59 Million JPY | -79.9% |
2010 Q1 | 52.69 Million JPY | -23.14% |
2010 FY | 149.81 Million JPY | -53.51% |
2010 Q3 | 88.68 Million JPY | 737.27% |
2009 Q2 | 104.33 Million JPY | -16.87% |
2009 FY | 322.21 Million JPY | 306.15% |
2009 Q4 | 68.54 Million JPY | 187.68% |
2009 Q3 | 23.82 Million JPY | -77.16% |
2009 Q1 | 125.5 Million JPY | 197.58% |
2008 Q3 | -58.28 Million JPY | -211.22% |
2008 Q4 | -128.61 Million JPY | -120.68% |
2008 FY | -156.29 Million JPY | 7.51% |
2008 Q2 | 52.4 Million JPY | 0.0% |
2007 FY | -168.98 Million JPY | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Kitanotatsujin Corporation | 994.66 Million JPY | 95.882% |
Euglena Co., Ltd. | -2.67 Billion JPY | 101.529% |
BEAUTY GARAGE Inc. | 1.08 Billion JPY | 96.224% |
Axas Holdings Co.,Ltd. | 31.37 Million JPY | -30.55% |
C.I. Medical Co.,Ltd. | 2.08 Billion JPY | 98.033% |
Kao Corporation | 43.87 Billion JPY | 99.907% |
Niitaka Co., Ltd. | 705.93 Million JPY | 94.198% |
Rohto Pharmaceutical Co.,Ltd. | 30.93 Billion JPY | 99.868% |
Shiseido Company, Limited | 21.74 Billion JPY | 99.812% |
Lion Corporation | 14.62 Billion JPY | 99.72% |
Mandom Corporation | 2.6 Billion JPY | 98.425% |
Ivy Cosmetics Corporation | 160.31 Million JPY | 74.452% |
Milbon Co., Ltd. | 4 Billion JPY | 98.977% |
Nippon Shikizai, Inc. | 398.11 Million JPY | 89.712% |
Fancl Corporation | 8.83 Billion JPY | 99.536% |
KOSÉ Corporation | 11.66 Billion JPY | 99.649% |
Cota Co., Ltd. | 1.34 Billion JPY | 96.965% |
HABA Laboratories,Inc. | -2.11 Billion JPY | 101.933% |
C'bon Cosmetics Co.,Ltd. | -26.34 Million JPY | 255.443% |
Pola Orbis Holdings Inc. | 9.66 Billion JPY | 99.576% |
Noevir Holdings Co., Ltd. | 7.67 Billion JPY | 99.466% |
Adjuvant Holdings Co.,Ltd. | -99.86 Million JPY | 141.011% |
Almado, Inc. | 695.45 Million JPY | 94.111% |
I-ne CO., LTD. | 3.95 Billion JPY | 98.964% |
Premier Anti-Aging Co., Ltd. | -1.48 Billion JPY | 102.762% |
Liberta Co.,Ltd. | 111.33 Million JPY | 63.213% |
AXXZIA Inc. | 794.34 Million JPY | 94.844% |
S.T. Corporation | 1.27 Billion JPY | 96.785% |
Kobayashi Pharmaceutical Co., Ltd. | 20.33 Billion JPY | 99.799% |
Earth Corporation | 4.1 Billion JPY | 99.002% |
Asahi Eito Holdings Co.,Ltd. | -623.21 Million JPY | 106.572% |
Ya-Man Ltd. | 398.33 Million JPY | 89.718% |
MTG Co., Ltd. | 1.98 Billion JPY | 97.936% |
TRANSACTION CO.,Ltd. | 3.76 Billion JPY | 98.912% |
SHOBIDO Corporation | 475.43 Million JPY | 91.386% |
Artnature Inc. | 1.46 Billion JPY | 97.199% |
Pigeon Corporation | 7.42 Billion JPY | 99.448% |
Unicharm Corporation | 86.05 Billion JPY | 99.952% |
Paltac Corporation | 20.63 Billion JPY | 99.802% |
CB GROUP MANAGEMENT Co., Ltd. | 2.05 Billion JPY | 98.009% |